释放黑色转移素 (CD228) 的潜力:对向药物开发和新的治疗途径的影响
Yanan Zhang1, Deyong Song1, Xiaolei Han1
1Research and Development Center, Shandong Boan Biotechnology Co., Ltd, Yantai, Shandong, China.
Expert opinion on therapeutic targets
|December 16, 2024
概括
黑色转移素 (CD228) 是一种在固体瘤中发现的有前途的癌症抗原. 向CD228为癌症治疗和诊断提供了治疗潜力,正在进行临床转化研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 黑色转移素 (CD228) 是一种细胞膜固的蛋白质,在各种固体瘤中高度表达.
- 它的表达表明它作为癌症抗原具有重要作用.
- 了解CD228的功能对于开发向癌症疗法至关重要.
研究的目的:
- 审查目前对CD228及其异构体的理解.
- 在瘤学中探索向CD228的治疗潜力.
- 要总结与CD228.8相关的药物开发工作.
主要方法:
- 使用PubMed,科学网络和临床试验.gov.gov进行全面的文献搜索.
- 使用的关键词:"黑色转移素"和"CD228".
- 审查的重点是CD228异型,瘤发生中的作用和药物开发.
主要成果:
- CD228有两个同位体:与膜结合 (mMFI2) 和溶解 (sMFI2).
- mMFI2与瘤发生,血管生成和细胞迁移有关.
- sMFI2对于诊断恶性瘤,阿尔茨海默氏症,关节炎和BBB的药物输送都很重要.
结论:
- 向CD228,特别是mMFI2,为固体瘤治疗提供了一个有希望的策略.
- sMFI2显示出诊断价值和提高药物输送的潜力.
- 需要进一步研究CD228导向疗法的临床转化.
更多相关视频
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
5.9K
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.4K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K